Structure

Physi-Chem Properties

Molecular Weight:  698.44
Volume:  724.186
LogP:  2.043
LogD:  0.986
LogS:  -3.335
# Rotatable Bonds:  24
TPSA:  162.5
# H-Bond Aceptor:  13
# H-Bond Donor:  2
# Rings:  0
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.163
Synthetic Accessibility Score:  5.308
Fsp3:  0.765
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.221
MDCK Permeability:  7.835897122276947e-06
Pgp-inhibitor:  0.999
Pgp-substrate:  0.973
Human Intestinal Absorption (HIA):  0.955
20% Bioavailability (F20%):  0.352
30% Bioavailability (F30%):  0.165

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.081
Plasma Protein Binding (PPB):  73.32122039794922%
Volume Distribution (VD):  0.705
Pgp-substrate:  22.485031127929688%

ADMET: Metabolism

CYP1A2-inhibitor:  0.0
CYP1A2-substrate:  0.058
CYP2C19-inhibitor:  0.027
CYP2C19-substrate:  0.798
CYP2C9-inhibitor:  0.066
CYP2C9-substrate:  0.038
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.073
CYP3A4-inhibitor:  0.453
CYP3A4-substrate:  0.889

ADMET: Excretion

Clearance (CL):  4.437
Half-life (T1/2):  0.699

ADMET: Toxicity

hERG Blockers:  0.001
Human Hepatotoxicity (H-HT):  0.862
Drug-inuced Liver Injury (DILI):  0.962
AMES Toxicity:  0.014
Rat Oral Acute Toxicity:  0.053
Maximum Recommended Daily Dose:  0.023
Skin Sensitization:  0.092
Carcinogencity:  0.016
Eye Corrosion:  0.003
Eye Irritation:  0.005
Respiratory Toxicity:  0.049

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473495

Natural Product ID:  NPC473495
Common Name*:   Pterulamide I
IUPAC Name:   (2S,3S)-N,3-dimethyl-2-[methyl-[(2S)-3-methyl-2-[[(2S)-3-methyl-2-[methyl-[(2S,3S)-3-methyl-2-[methyl-[(2S)-2-[methyl-[(E)-3-methylsulfinylprop-2-enoyl]amino]propanoyl]amino]pentanoyl]amino]butanoyl]amino]butanoyl]amino]pentanamide
Synonyms:   pterulamide I
Standard InCHIKey:  VJHQQCCKXFLKLU-QZFMFPMKSA-N
Standard InCHI:  InChI=1S/C34H62N6O7S/c1-16-22(7)28(30(42)35-10)39(13)33(45)26(20(3)4)36-31(43)27(21(5)6)38(12)34(46)29(23(8)17-2)40(14)32(44)24(9)37(11)25(41)18-19-48(15)47/h18-24,26-29H,16-17H2,1-15H3,(H,35,42)(H,36,43)/b19-18+/t22-,23-,24-,26-,27-,28-,29-,48?/m0/s1
SMILES:  CC[C@@H]([C@H](N(C(=O)[C@@H](N(C(=O)/C=C/S(=O)C)C)C)C)C(=O)N([C@H](C(=N[C@H](C(=O)N([C@H](C(=NC)O)[C@H](CC)C)C)C(C)C)O)C(C)C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL443715
PubChem CID:   16091506
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000348] Peptides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33341 pterula sp. Species Pterulaceae Eukaryota n.a. Malaysian n.a. PMID[17067148]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT168 Cell Line P388 Mus musculus IC50 = 790.0 nM PMID[556090]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473495 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7333 Intermediate Similarity NPC6902
0.7333 Intermediate Similarity NPC184473
0.7333 Intermediate Similarity NPC284456
0.7158 Intermediate Similarity NPC155230
0.7143 Intermediate Similarity NPC53858
0.7143 Intermediate Similarity NPC84128
0.6989 Remote Similarity NPC472351
0.6739 Remote Similarity NPC476117
0.6739 Remote Similarity NPC476243
0.6739 Remote Similarity NPC476156
0.6739 Remote Similarity NPC476137
0.67 Remote Similarity NPC38172
0.6667 Remote Similarity NPC23984
0.6667 Remote Similarity NPC476302
0.663 Remote Similarity NPC31756
0.6629 Remote Similarity NPC209156
0.6526 Remote Similarity NPC235078
0.6509 Remote Similarity NPC471097
0.6509 Remote Similarity NPC475149
0.6444 Remote Similarity NPC161774
0.6444 Remote Similarity NPC256312
0.6444 Remote Similarity NPC266888
0.6408 Remote Similarity NPC469739
0.6404 Remote Similarity NPC196007
0.6404 Remote Similarity NPC76297
0.6404 Remote Similarity NPC214532
0.6364 Remote Similarity NPC171734
0.6364 Remote Similarity NPC207820
0.6321 Remote Similarity NPC475791
0.6321 Remote Similarity NPC13175
0.6293 Remote Similarity NPC239357
0.6275 Remote Similarity NPC471098
0.6275 Remote Similarity NPC173763
0.6275 Remote Similarity NPC62263
0.6261 Remote Similarity NPC473819
0.625 Remote Similarity NPC117829
0.6226 Remote Similarity NPC475758
0.619 Remote Similarity NPC144780
0.6176 Remote Similarity NPC474576
0.6174 Remote Similarity NPC472536
0.6174 Remote Similarity NPC103391
0.6162 Remote Similarity NPC477539
0.6154 Remote Similarity NPC280066
0.6147 Remote Similarity NPC476877
0.6105 Remote Similarity NPC312315
0.6078 Remote Similarity NPC474593
0.6078 Remote Similarity NPC475801
0.6075 Remote Similarity NPC220234
0.6071 Remote Similarity NPC296143
0.6058 Remote Similarity NPC301010
0.6038 Remote Similarity NPC473597
0.6036 Remote Similarity NPC476876
0.5979 Remote Similarity NPC470783
0.5966 Remote Similarity NPC469899
0.5909 Remote Similarity NPC124554
0.5909 Remote Similarity NPC5864
0.5909 Remote Similarity NPC301148
0.5888 Remote Similarity NPC134504
0.5888 Remote Similarity NPC47076
0.5865 Remote Similarity NPC477538
0.5851 Remote Similarity NPC477863
0.5843 Remote Similarity NPC84182
0.5843 Remote Similarity NPC128005
0.5804 Remote Similarity NPC323720
0.5804 Remote Similarity NPC124549
0.5781 Remote Similarity NPC300315
0.578 Remote Similarity NPC475440
0.5776 Remote Similarity NPC476875
0.5758 Remote Similarity NPC246005
0.5752 Remote Similarity NPC241394
0.5745 Remote Similarity NPC477862
0.5729 Remote Similarity NPC59867
0.5714 Remote Similarity NPC306696
0.5714 Remote Similarity NPC288109
0.5714 Remote Similarity NPC250953
0.5714 Remote Similarity NPC296043
0.5714 Remote Similarity NPC198344
0.5714 Remote Similarity NPC47230
0.5714 Remote Similarity NPC17143
0.5714 Remote Similarity NPC89489
0.5684 Remote Similarity NPC327272
0.5667 Remote Similarity NPC329216
0.5664 Remote Similarity NPC128303
0.566 Remote Similarity NPC315237
0.5657 Remote Similarity NPC475542
0.5656 Remote Similarity NPC470546
0.5652 Remote Similarity NPC67009
0.5638 Remote Similarity NPC315897
0.5635 Remote Similarity NPC22746
0.562 Remote Similarity NPC322878
0.5614 Remote Similarity NPC475637
0.561 Remote Similarity NPC315188
0.561 Remote Similarity NPC160688

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473495 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7033 Intermediate Similarity NPD7762 Phase 2
0.7033 Intermediate Similarity NPD7763 Phase 2
0.6667 Remote Similarity NPD5791 Phase 2
0.663 Remote Similarity NPD4815 Discontinued
0.65 Remote Similarity NPD5792 Clinical (unspecified phase)
0.6495 Remote Similarity NPD7760 Phase 2
0.6495 Remote Similarity NPD7759 Phase 2
0.6458 Remote Similarity NPD3733 Clinical (unspecified phase)
0.6422 Remote Similarity NPD2147 Approved
0.6421 Remote Similarity NPD2683 Discontinued
0.6289 Remote Similarity NPD9577 Approved
0.6168 Remote Similarity NPD6120 Clinical (unspecified phase)
0.6162 Remote Similarity NPD3723 Clinical (unspecified phase)
0.6038 Remote Similarity NPD1784 Approved
0.6 Remote Similarity NPD620 Approved
0.6 Remote Similarity NPD2090 Approved
0.5981 Remote Similarity NPD8038 Phase 2
0.5943 Remote Similarity NPD7841 Clinical (unspecified phase)
0.5935 Remote Similarity NPD8041 Phase 2
0.5934 Remote Similarity NPD9649 Approved
0.578 Remote Similarity NPD4825 Clinical (unspecified phase)
0.5778 Remote Similarity NPD9666 Clinical (unspecified phase)
0.5778 Remote Similarity NPD9665 Clinical (unspecified phase)
0.5758 Remote Similarity NPD1125 Discovery
0.575 Remote Similarity NPD2099 Approved
0.5728 Remote Similarity NPD3177 Phase 3
0.5714 Remote Similarity NPD322 Phase 1
0.5714 Remote Similarity NPD4261 Phase 1
0.5714 Remote Similarity NPD9578 Clinical (unspecified phase)
0.57 Remote Similarity NPD7643 Phase 1
0.566 Remote Similarity NPD6699 Clinical (unspecified phase)
0.5638 Remote Similarity NPD266 Phase 3
0.5638 Remote Similarity NPD1825 Clinical (unspecified phase)
0.5638 Remote Similarity NPD265 Phase 3
0.563 Remote Similarity NPD2100 Approved
0.5619 Remote Similarity NPD1782 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data